BlogOctober 26, 2022 Silo Pharma to Discuss Mainstream Pharma and Psychedelics at Wonderland Miami Conference
PressOctober 25, 2022 Silo Pharma – Distinctive with Ground-Breaking Research, Commitment to Developing Innovative Solutions
PressOctober 25, 2022 IntelGenx Receives FDA GDUFA Date for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film
PressOctober 25, 2022 atai Life Sciences Company, Perception Neuroscience, Completes Enrollment for Phase 2a Clinical Trial of PCN-101 (R-Ketamine) for Treatment-Resistant Depression
PressOctober 24, 2022 Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs
PressOctober 24, 2022 Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited
PressOctober 24, 2022 Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study
PressOctober 20, 2022 Albert Labs Files New International PCT Patent Application for scalable API manufacturing
PressOctober 20, 2022 Silo Wellness Announces LOI for Potentially Largest Psilocybin Retreat Center in Oregon and the World – If November’s Election Is Favorable; and an Oregon Real Estate Law and Psilocybin Industry Primer
PressOctober 19, 2022 Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland
PressOctober 18, 2022 atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial for Its Sol-gel Based Direct-to-Brain Drug Delivery Technology
PressOctober 18, 2022 Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety Therapeutics
PressOctober 18, 2022 Silo Pharma Stock Higher After Investors Appraise Innovative Treatment For Nerve Pain And Neurological Disorders
PressOctober 18, 2022 Silo Wellness Closes Acquisition of Dyscovry Science and Its Psilocybin Pharmaceutical Biosynthesis and Research Portfolio
PressOctober 18, 2022 Wellbeing Digital Subsidiary KGK to Participate in the Supply Side West Conference
PressOctober 17, 2022 European University to Fund Core One Labs Akome Advanced Neurogenesis Stimulation Studies
